TMCnet News
Research and Markets: Interactive CD-ROM Delivers the Latest Liver Cancer Drug Pipeline Update for 2009Dublin, Feb 19, 2009 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/b1d663/liver_cancer_drug) has announced the addition of the "Liver Cancer Drug Pipeline Update 2009" report to their offering. There are today at least 107 therapeutics targeting liver cancer in active development, from early preclinical to marketed drugs. In addition, the accumulated number of ceased drugs over the last three years amount to another 34 drugs. Liver Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 75 different targets. These targets are further categorized on the CD-ROM by 34 classifications of molecular function and with pathway referals to BioCarta, KEGG and NetPath. Read more below on how the Liver Cancer Drug Pipeline Update is organized. How May Drug Pipeline Update Be of Use? - Show investors/board/management that you are right on top of drug development progress in your therapeutic area. - Find competitors, collaborations partners, M&A candidates etc. - Jump start competitive drug intelligence operations - Excellent starting point for world wide benchmarking - Compare portfolio and therapy focus with your peers - Speed up pro-active in-/out licensing strategy work - Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug. - Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below. Drug Pipeline Update at a Glance Investigators Includes 113 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators. Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator. Drug name & Synonyms Lists commercial, generic and code names for drugs. In all more than 150 names Developmental stage This Drug Pipeline Update contains 107 drugs in active development for the treatment of liver cancer: Indications Included liver cancer drugs are also in development for 78 other indications. Targets Identified drugs are linked to more than 75 different targets, divided into 34 classifications of molecular function Identified targets are categorized into 19 different primary and alternate sub-cellular localizations Target Expression Profile Direct links are provided from inside the application to 91 protein expression profiles of 60 drug targets in various human tissues and cancer types, cell lines and primary cells, includin up to - 48 different normal tissue types - 20 different types of cancer - 47 cell lines - 12 samples of primary blood cells Pathway Referals Identified targets have been cross referenced against their invovlement in different cellular pathways, according to BioCarta, KEGG and NetPath: - BioCarta 166 Pathways - KEGG 57 Pathways - NetPath 19 Signaling Pathways Mechanism In total there are 99 different drug mechanism of action represented in this Drug Pipeline Update. Compound Identified drug compounds are described by: Compound type, Chemical name, CAS Number and molecular weight Drug Profile Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information: - Drug Name & Synonyms - Principal Investigator & Partners - Target and Molecular Function of Target - Target Localization - Target Expression Profiles - Targeted Pathways - Mechanism - Developmental Projects - Drug Description - Compound Data - Patent Data - Business & Markets - Phase III Data - Phase II Data - Phase I Data - Preclinical Data - Licensing Information Application Features Use 13 different parameters, available in drop-down menus, to find and sort among drugs For more information visit http://www.researchandmarkets.com/research/b1d663/liver_cancer_drug CONTACT: Laura Wood, Senior Manager, Research and Markets Fax: +1 646 607 1907 (US) Fax: +353 1 481 1716 (Rest of World) e-mail: [email protected] M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected]. |